Immunome (IMNM)
NASDAQ:IMNM
US Market
Holding IMNM?
Track your performance easily

Immunome (IMNM) Financial Statements

192 Followers

Immunome Financial Overview

Immunome's market cap is currently ―. The company's EPS TTM is $-7.691; its P/E ratio is -2.02; Immunome is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.36M$ 1.03M$ 3.83M$ 3.56M$ 4.26M
Gross Profit$ 2.36M$ 1.03M$ 3.83M$ 3.56M$ 4.26M
EBIT$ -40.01M$ -20.34M$ -13.85M$ -4.63M$ -5.77M
EBITDA$ -38.80M$ -20.08M$ -13.59M-$ -5.62M
Net Income Common Stockholders$ -36.12M$ -129.49M$ -92.63M$ -4.34M$ -5.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 278.30M$ 309.70M$ 138.14M$ 90.64M$ 38.42M
Total Assets$ 296.21M$ 319.75M$ 148.54M$ 93.16M$ 41.44M
Total Debt$ 2.48M$ 1.21M$ 0.00$ 0.00$ 0.00
Net Debt$ -275.82M$ -308.49M$ -138.14M$ -90.64M$ -38.42M
Total Liabilities$ 42.38M$ 34.18M$ 28.66M$ 87.08M$ 32.10M
Stockholders Equity$ 253.84M$ 285.57M$ 119.88M$ 6.08M$ 9.37M
Cash Flow-
Free Cash Flow$ -10.73M$ -28.34M$ -17.81M-$ -6.01M
Operating Cash Flow$ -23.40M$ -11.17M$ -17.46M$ -8.61M$ -5.67M
Investing Cash Flow$ -81.69M$ -37.23M$ -30.00M$ -36.00K$ -340.00K
Financing Cash Flow$ 694.00K$ 219.44M$ 55.50M$ 60.88M-
Currency in USD

Immunome Earnings and Revenue History

Immunome Debt to Assets

Immunome Cash Flow

Immunome Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis